Prostate Cancer Biomarker Assay
A methylated DNA classifier to identify prostate cancer with over 90% sensitivity and specificity
Published: 15th February 2021

Patents
- Filed PCT Patent WO 2020/069610 A1 "Prostate Cancer Biomarker Assays"
IP Status
- Patent application submitted
Seeking
- Licensing
- Seeking investment
- Development partner